Author

L. K. Pham

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Aderem· 1 shared A. C. Rothchild· 1 shared A. H. Diercks· 1 shared A. Jahn· 1 shared B. M. Nagalo· 1 shared D. Mai· 1 shared J. C. Chamcheu· 1 shared J. C. Nemeth· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Aderem

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Exposure to mycobacterium remodels alveolar macrophages and the early innate response to Mycobacterium tuberculosis infection

D. Mai, A. Jahn, T. Murray, M. Morikubo, P. N. Lim, M. M. Cervantes, L. K. Pham, J. C. Nemeth, K. B. Urdahl, A. H. Diercks, A. Aderem, A. C. Rothchild

This study shows that prior exposure to mycobacteria remodels alveolar macrophages, enhancing their pro-inflammatory response to Mtb infection through both intrinsic changes and environmental factors.

bioRxiv · Sep 19, 2022Immunology

Identification of potential inhibitors of cutaneous Melanoma and Non-Melanoma skin cancer cells through in vitro and in silico screening of a small library of Phenolic compounds

S. T. Boateng, T. Roy, M. E. Agbo, S. Banang-Mbeumi, R.-C. N. Chamcheu, M. Bramwell, L. K. Pham, K. E. Jackson, R. A. Hill, B. M. Nagalo, T. Efimova, J. Fotie, J. C. Chamcheu

This study screens a small library of phenolic compounds in vitro and in silico to identify potential inhibitors of melanoma and non-melanoma skin cancer cells, finding several compounds with significant antitumor activity and selectivity.

bioRxiv · Feb 28, 2022 · PreprintPharmacology & Toxicology